IMRX – immuneering corporation - class a (US:NASDAQ)
Stock Stats
News
Immuneering (IMRX) Valuation After Strong Phase 2a Pancreatic Cancer Data And Planned Phase 3 Transition [Yahoo! Finance]
Why Immuneering (IMRX) Is Down 29.7% After Positive Phase 2a Pancreatic Cancer Survival Update And What's Next [Yahoo! Finance]
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data [Seeking Alpha]
Immuneering Announces Exceptional 64% Overall Survival At 12 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
Immuneering: Clinical Catalyst In January, Cash Raised For Phase 3 [Seeking Alpha]
Form 4 Immuneering Corp For: Jan 15 Filed by: Hall Brett Matthew
Form SCHEDULE 13G/A Immuneering Corp Filed by: Empery Asset Management, LP
Form 4 Immuneering Corp For: Jan 13 Filed by: Neufeld Leah R
Form 4 Immuneering Corp For: Jan 12 Filed by: Feinberg Peter
Form 8-K Immuneering Corp For: Jan 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.